Reza Ghorbani, MD
Pain Medicine · Greenbelt, MDNPI 1033194584
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $20,123 of the $24,432 with a category attached, or 82.4%. 22 manufacturers reported payments, led by Abbott at 44.9% of the total. Reporting peaked in 2022 at $6,164 and has fallen 69.0% since, to $1,912 in 2025. Among pain medicine clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 577 payments — averaging $42.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$11K
- Boston Scientific$6K
- Medtronic$3K
- Spinal Simplicity, LLC$2K
- Nevro Corp.$856
- Collegium Pharmaceutical, Inc.$387
- plus $1K from 16 others
What the payments were for
- Travel & lodging$4,31018%
- Food & beverage$20,12382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 288 | $10,969 |
| Boston Scientific | 156 | $6,033 |
| Medtronic(2 entities) | 53 | $2,922 |
| Spinal Simplicity, LLC | 8 | $1,924 |
| Nevro Corp. | 21 | $856 |
| Collegium Pharmaceutical, Inc. | 22 | $387 |
| Si-bone, Inc. | 3 | $338 |
| Spinefrontier, Inc. | 1 | $223 |
| Vertos Medical, Inc. | 1 | $168 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $144 |
| Intrinsic Therapeutics | 1 | $137 |
| Bioventus LLC | 1 | $83 |
| Pfizer | 3 | $46 |
| Painteq LLC | 1 | $27 |
| Cumberland Pharmaceuticals, Inc. | 1 | $25 |
| Orexo US, Inc. | 1 | $25 |
| Johnson & Johnson | 2 | $24 |
| Medline Industries LP | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $23 |
| SPR Therapeutics, Inc | 1 | $21 |
| GRT US Holding, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,493
- WaveWriter Alpha Prime 16$2,068
- HA MINUTEMAN G3-R$1,820
- Proclaim Family of SCS IPGs$1,271
- Proclaim IPG$1,256
- INTELLIS$1,249
- Axium$1,026
- Infinion 16$744
- Vanta$692
- LIBERTY SI$521
- INTELLIS ADAPTIVESTIM$400
- Octrode SCS Leads$317
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$274
- Omnia$235
- InSpan$223
- mild Device Kit$168
- iFuse Implant$148
- Axium INS DRG IPG$145
- GENERAL VASCULAR ACCESS$137
- Senza Spinal Cord Stimulation System$137
How this compares
$24,432 in reported general payments places this provider in the 90th percentile of 144 pain medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 76 | $40,065 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,030 | $24,177 |
| Xtampza ErOxycodone Myristate | 31 | $23,754 |
| Lidocaine | 192 | $18,768 |
| Oxycodone Hcl | 1,025 | $11,593 |
| MovantikNaloxegol Oxalate | 25 | $9,053 |
| Fentanyl | 80 | $7,678 |
| Gabapentin | 844 | $7,567 |
| Pregabalin | 351 | $7,228 |
| CelebrexCelecoxib | 13 | $5,553 |
| Diclofenac Sodium | 142 | $4,414 |
| Cyclobenzaprine Hcl | 382 | $3,763 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 161 | $3,752 |
| Tizanidine Hcl | 248 | $2,771 |
| Morphine Sulfate ErMorphine Sulfate | 96 | $1,845 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $387 | $23,75431 claims |
| PfizerCelebrex | $46 | $5,55313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 144 pain medicine providers in Maryland.
Other pain medicine in Greenbelt
- Haddis HagosGreenbelt$8K
- Netsere TesfayohannesGreenbelt$5K
- Vipul MangalOxon Hill$764K
- Randy DavisBaltimore$169K
- Paul ChristoBaltimore$137K
- Kunal SoodGermantown$70K
- Ali TurabiBethesda$47K
- Behnam JafarpourBaltimore$45K
- Eric FinkelsteinOwings Mills$37K
- Ankush JainBethesda$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.